203 related articles for article (PubMed ID: 38512652)
1. Neuroprotective effects of rutin against cuprizone-induced multiple sclerosis in mice.
Nicola MA; Attaai AH; Abdel-Raheem MH; Mohammed AF; Abu-Elhassan YF
Inflammopharmacology; 2024 Apr; 32(2):1295-1315. PubMed ID: 38512652
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective Effects of Telmisartan and Nifedipine Against Cuprizone-Induced Demyelination and Behavioral Dysfunction in Mice: Roles of NF-κB and Nrf2.
Abd El Aziz AE; Sayed RH; Sallam NA; El Sayed NS
Inflammation; 2021 Aug; 44(4):1629-1642. PubMed ID: 33709265
[TBL] [Abstract][Full Text] [Related]
3. Metformin Therapy Attenuates Pro-inflammatory Microglia by Inhibiting NF-κB in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis.
Abdi M; Pasbakhsh P; Shabani M; Nekoonam S; Sadeghi A; Fathi F; Abouzaripour M; Mohamed W; Zibara K; Kashani IR; Zendedel A
Neurotox Res; 2021 Dec; 39(6):1732-1746. PubMed ID: 34570348
[TBL] [Abstract][Full Text] [Related]
4. Remyelinating activities of Carvedilol or alpha lipoic acid in the Cuprizone-Induced rat model of demyelination.
Ibrahim Fouad G; Ahmed KA
Int Immunopharmacol; 2023 May; 118():110125. PubMed ID: 37028277
[TBL] [Abstract][Full Text] [Related]
5. Coenzyme Q10 enhances remyelination and regulate inflammation effects of cuprizone in corpus callosum of chronic model of multiple sclerosis.
Khalilian B; Madadi S; Fattahi N; Abouhamzeh B
J Mol Histol; 2021 Feb; 52(1):125-134. PubMed ID: 33245472
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: A pivotal role of AMPK/SIRT1 and JAK2/STAT3/NF-κB signalling pathway modulation.
Elbaz EM; Senousy MA; El-Tanbouly DM; Sayed RH
Toxicol Appl Pharmacol; 2018 Aug; 352():153-161. PubMed ID: 29864483
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal Stem Cells Ameliorate Cuprizone-Induced Demyelination by Targeting Oxidative Stress and Mitochondrial Dysfunction.
Shiri E; Pasbakhsh P; Borhani-Haghighi M; Alizadeh Z; Nekoonam S; Mojaverrostami S; Pirhajati Mahabadi V; Mehdi A; Zibara K; Kashani IR
Cell Mol Neurobiol; 2021 Oct; 41(7):1467-1481. PubMed ID: 32594382
[TBL] [Abstract][Full Text] [Related]
8. Calorie restriction promotes remyelination in a Cuprizone-Induced demyelination mouse model of multiple sclerosis.
Mojaverrostami S; Pasbakhsh P; Madadi S; Nekoonam S; Zarini D; Noori L; Shiri E; Salama M; Zibara K; Kashani IR
Metab Brain Dis; 2020 Oct; 35(7):1211-1224. PubMed ID: 32638202
[TBL] [Abstract][Full Text] [Related]
9. Cordycepin (3'-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of demyelination.
Jia Y; Li H; Bao H; Zhang D; Feng L; Xiao Y; Zhu K; Hou Y; Luo S; Zhang Y; Xiao L; Chen X; Zhou J; Wang C; Wang G; Yu H; Xiao C; Du J
Int Immunopharmacol; 2019 Oct; 75():105777. PubMed ID: 31357085
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase-5 inhibition promotes remyelination by MCP-1/CCR-2 and MMP-9 regulation in a cuprizone-induced demyelination model.
Nunes AK; Rapôso C; de Oliveira WH; Thomé R; Verinaud L; Tovar-Moll F; Peixoto CA
Exp Neurol; 2016 Jan; 275 Pt 1():143-53. PubMed ID: 26515692
[TBL] [Abstract][Full Text] [Related]
11. The neuroprotective effects of Chalcones from Ashitaba on cuprizone-induced demyelination via modulation of brain-derived neurotrophic factor and tumor necrosis factor α.
Rowhanirad S; Taherianfard M
Brain Behav; 2023 Sep; 13(9):e3144. PubMed ID: 37403256
[TBL] [Abstract][Full Text] [Related]
12. Combination Therapy of Mesenchymal Stem Cell Transplantation and Astrocyte Ablation Improve Remyelination in a Cuprizone-Induced Demyelination Mouse Model.
Madadi S; Shiri E; Pasbakhsh P; Tahmasebi F; Kazemzadeh S; Zibara K; Kashani IR
Mol Neurobiol; 2022 Dec; 59(12):7278-7292. PubMed ID: 36175823
[TBL] [Abstract][Full Text] [Related]
13. Repurposing of Secukinumab as Neuroprotective in Cuprizone-Induced Multiple Sclerosis Experimental Model via Inhibition of Oxidative, Inflammatory, and Neurodegenerative Signaling.
Abdel-Maged AE; Gad AM; Rashed LA; Azab SS; Mohamed EA; Awad AS
Mol Neurobiol; 2020 Aug; 57(8):3291-3306. PubMed ID: 32514862
[TBL] [Abstract][Full Text] [Related]
14. Protective and therapeutic role of Bilobalide in cuprizone-induced demyelination.
Sui RX; Miao Q; Wang J; Wang Q; Song LJ; Yu JW; Cao L; Xiao W; Xiao BG; Ma CG
Int Immunopharmacol; 2019 Jan; 66():69-81. PubMed ID: 30445309
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study.
Ghaiad HR; Nooh MM; El-Sawalhi MM; Shaheen AA
Mol Neurobiol; 2017 Jul; 54(5):3219-3229. PubMed ID: 27067589
[TBL] [Abstract][Full Text] [Related]
16. Trifluoperazine reduces cuprizone-induced demyelination via targeting Nrf2 and IKB in mice.
Khaledi E; Noori T; Mohammadi-Farani A; Sureda A; Dehpour AR; Yousefi-Manesh H; Sobarzo-Sanchez E; Shirooie S
Eur J Pharmacol; 2021 Oct; 909():174432. PubMed ID: 34416238
[TBL] [Abstract][Full Text] [Related]
17. Multiple functional therapeutic effects of DL-3-n-butylphthalide in the cuprizone model of demyelination.
Wu Y; Dong L; Huang Q; Sun L; Liao Y; Tang Y; Wu Y
Life Sci; 2019 Sep; 232():116501. PubMed ID: 31163175
[TBL] [Abstract][Full Text] [Related]
18. Ameliorative effects of acetyl-L-carnitine on corpus callosum and functional recovery in demyelinated mouse model.
Gharighnia S; Omidi A; Ragerdi Kashani I; Sepand MR; Pour Beiranvand S
Int J Neurosci; 2024 Apr; 134(4):409-419. PubMed ID: 35912879
[TBL] [Abstract][Full Text] [Related]
19. Effects of Bone Marrow Mesenchymal Stem Cells on Myelin Repair and Emotional Changes of a Cuprizone-Induced Demyelination Model.
Lei C; Chen H; Chen K
J Integr Neurosci; 2023 Feb; 22(2):40. PubMed ID: 36992584
[TBL] [Abstract][Full Text] [Related]
20. The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives.
Gharagozloo M; Galleguillos D; Jank L; Sotirchos ES; Smith MD; Garton T; Kumar S; Hussein O; Potluri S; Taylor M; Siu C; Mace JW; Dawson T; Dawson VL; Lee S; Calabresi PA
Neurotherapeutics; 2023 Jul; 20(4):1229-1240. PubMed ID: 37296356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
